| Item 1. | |
| (a) | Name of issuer:
Community Health Systems, Inc. |
| (b) | Address of issuer's principal executive offices:
4000 Meridian Boulevard, Franklin, TN, 37067 |
| Item 2. | |
| (a) | Name of person filing:
This statement is jointly filed by and on behalf of Eversept Partners, L.P., a Delaware limited partnership (the "Investment Manager"), Eversept 1 LLC, a Delaware limited liability company (the "IM GP") and Kamran Moghtaderi (collectively referred herein as "Reporting Persons"). The Investment Manager is the investment manager of advisory clients and may be deemed to indirectly beneficially own securities owned by its advisory clients. The IM GP is the general partner of the Investment Manager and may be deemed to indirectly beneficially own securities owned by the Investment Manager. Mr. Moghtaderi is the sole manager of and may be deemed to beneficially own securities beneficially owned by the IM GP. Eversept's advisory clients are the record and direct beneficial owners of the securities covered by this statement.
Each Reporting Person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or 13(g) of the Act or any other purpose, the beneficial owner of any securities covered by this statement.
Each Reporting Person may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purpose of Section 13(d) or 13(g) of the Act. Each of the Reporting Persons declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purpose of Section 13(d) or 13(g) of the Act or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding, or disposing of securities of the issuer or otherwise with respect to the issuer or any securities of the issuer or (ii) a member of any group with respect to the issuer or any securities of the issuer. |
| (b) | Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is c/o Eversept Partners, L.P., 444 Madison Avenue, 22nd Floor, New York, NY 10022. |
| (c) | Citizenship:
See Item 4 on the cover page hereto. |
| (d) | Title of class of securities:
Common Stock, par value $0.01 per share |
| (e) | CUSIP No.:
203668108 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) |  An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
6,144,384 |
| (b) | Percent of class:
4.4%** |
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
5,463,507
|
| | (ii) Shared power to vote or to direct the vote:
680,877*
|
| | (iii) Sole power to dispose or to direct the disposition of:
5,463,507
|
| | (iv) Shared power to dispose or to direct the disposition of:
680,877*
* Note: As of the close of business on June 30, 2025, Eversept and its controlling persons beneficially owned 6,144,384 Shares, including 680,877 Shares held in Eversept's Managed Accounts.
** Note: As of June 30, 2025, Eversept and its controlling persons were the beneficial owners of approximately 4.4% of the outstanding Shares, based on 140,306,440 shares of Common Stock of the Issuer outstanding as of April 17, 2025, as reported in the Issuer's Form 10-Q filed on April 24, 2025, including 0.5% of the outstanding Shares held in Eversept's Managed Accounts.
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| |
Ownership of 5 percent or less of a class
|
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
Not Applicable
|
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|